Maihgan A Kavanagh, MD
Surgical Oncology · Santa Clara
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Offices
- 2
- Since medical school
- 29 years
- University of California, Geffen School of Medicine, 1997
Offices
2 locations · Permanente Medical Group Inc · 10,928 clinicians in this group
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Kavanagh’s office at (408) 851-1000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
California Medical Board record
Licence A86552 · Current
Licensed to practise in California · since 2004 · expires 2027-08-31 · University of California, Los Angeles School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Surgery - Surgery
Original Medicare doctor bills
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Procedures Medicare counted
| Mastectomy | 1-10 | None |
Drugs they prescribed that Part D paid
$1,424
Pharmacies billed $1,424 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 38% of their Part D prescriptions (62 of 164) in 2024. Above the middle of the specialty; the typical surgical oncology clinician is at 36%. Surgeons prescribe little besides pain medicine after an operation, so their opioid share runs high.
164 generic and 0 brand-name prescriptions · $1,424 in drug cost · 23 antibiotic prescriptions to 12 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ibuprofen | 43 | $404 | $9 |
| Oxycodone | 61 | $375 | $6 |
| Gavilyte-C | 11 | $247 | $22 |
| Ondansetron Odt | 24 | $151 | $6 |
Year by year
| 2024 | 164 | 68 | 38% (62) | 0% | $1,424 |
| 2023 | 104 | 52 | 37% (38) | 0% | $891 |
| 2022 | 139 | 60 | 35% (48) | None | $1,469 |
| 2021 | 137 | 55 | 31% (43) | None | $3,082 |
| 2020 | 105 | 46 | 33% (35) | None | $1,312 |
| 2019 | 122 | 60 | 39% (48) | None | $1,592 |
| 2018 | 127 | 60 | 39% (50) | None | $2,093 |
| 2017 | 103 | 52 | 35% (36) | 0% | $1,461 |
| 2016 | 77 | 45 | 46% (35) | None | $1,398 |
| 2015 | 123 | 74 | 64% (79) | None | $2,395 |
| 2014 | 111 | 75 | 66% (73) | None | $1,518 |
| 2013 | 112 | 70 | 69% (77) | None | $2,029 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Ibuprofen | 30 | $282 | $9 |
| Oxycodone | 34 | $210 | $6 |
| Ondansetron Odt | 11 | $68 | $6 |
2022: 3 drugs
| Ibuprofen | 44 | $415 | $9 |
| Oxycodone | 41 | $234 | $6 |
| Ondansetron Odt | 21 | $133 | $6 |
2021: 3 drugs
| Ibuprofen | 43 | $415 | $10 |
| Oxycodone | 38 | $224 | $6 |
| Ondansetron Odt | 18 | $123 | $7 |
2020: 2 drugs
| Ibuprofen | 32 | $318 | $10 |
| Oxycodone | 31 | $181 | $6 |
2019: 3 drugs
| Ibuprofen | 42 | $487 | $12 |
| Oxycodone | 31 | $175 | $6 |
| Hydrocodone-Acetaminophen | 16 | $119 | $7 |
2018: 2 drugs
| Ibuprofen | 43 | $883 | $21 |
| Hydrocodone-Acetaminophen | 44 | $287 | $7 |
2017: 2 drugs
| Ibuprofen | 22 | $493 | $22 |
| Hydrocodone-Acetaminophen | 31 | $406 | $13 |
2016: 1 drug
| Hydrocodone-Acetaminophen | 24 | $494 | $21 |
2015: 2 drugs
| Hydrocodone-Acetaminophen | 58 | $1,164 | $20 |
| Gavilyte-C | 11 | $187 | $17 |
2014: 1 drug
| Hydrocodone-Acetaminophen | 66 | $736 | $11 |
2013: 1 drug
| Hydrocodone-Acetaminophen | 64 | $686 | $11 |
Money from drug and device companies
$35 in 2020
A payment is not proof that care is biased.
| Davol | Phasix | $35 | 1 payment
|
See the published payment
| Davol | Meals · 2020-05-28 | Phasix | $35 |
Professional record
- NPI
- 1790859395
- Licence
- CA A86552California A86552: Current · expires 2027-08-31
- Trained
- University of California, Geffen School of Medicine, 1997 · 29 years ago
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Surgery (208600000X)
- Mailing address
- 1800 Harrison St Fl 7, Oakland, CA, 94612
- NPI first listed
- 2006-11-17
- NPI last updated
- 2021-12-13
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.